1. 145PExpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical response to CDK4/6 inhibitors in breast cancer. (23rd October 2018) Authors: Crucitta, S; Del Re, M; Fontana, A; Bertolini, I; Rofi, E; De Angelis, C; Diodati, L; Cavallero, D; Salvadori, B; Falcone, A; Morganti, R; Danesi, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 169PSelective induction of PD-L1 expression in plasma-derived exosomes by gemcitabine-nab-paclitaxel vs. FOLFIRINOX in pancreas cancer. (23rd October 2018) Authors: Rofi, E; Del Re, M; Vivaldi, C; Crucitta, S; Arrigoni, E; Pasquini, G; Catanese, S; Pecora, I; Musettini, G; Vasile, E; Falcone, A; Danesi, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 88PRole of AR-V7 and AR-FL in resistance to hormonal therapy in mCRPC: Independent actors or reciprocal drivers? A translational study by Meet-Uro group. (23rd October 2018) Authors: Del Re, M; Crucitta, S; Sbrana, A; Rofi, E; Paolieri, F; Galli, L; Falcone, A; van Schaik, R; Jenster, G; Morganti, R; Pignata, S; Danesi, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. O-007Liquid biopsy allows predicting benefit from rechallenge with cetuximab(cet)+irinotecan(iri) in RAS/BRAF wild-type mCRC patients(pts) with resistance to 1st-line cet+iri: Final results and translational analyses of the CRICKET study by GONO. (20th June 2018) Authors: Rossini, D; Cremolini, C; Conca, E; Del Re, M; Busico, A; Pietrantonio, F; Bergamo, F; Danesi, R; Cardellino, G; Tamburini, E; Dell'Aquila, E; Strippoli, A; Masi, G; Tonini, G; Negri, F; Corsi, D; Pella, N; Intini, R; Falcone, A; Santini, D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Predicting fluoropyrimidine-related toxicity: turning wish to will, the PAMM-EORTC position. (18th July 2018) Authors: Ciccolini, J; Del Re, M; Danesi, R; Milano, G; Schellens, J H M; Raymond, E Journal: Annals of oncology Issue: Volume 29:Number 9(2018) Page Start: 1893 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Synergistic interaction between PPAR ligands and salbutamol on human bronchial smooth muscle cell proliferation. (18th December 2012) Authors: Fogli, S; Stefanelli, F; Picchianti, L; Del Re, M; Mey, V; Bardelli, C; Danesi, R; Breschi, MC Journal: British journal of pharmacology Issue: Volume 168:Number 1(2013:Jan.) Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Synergistic interaction between PPAR ligands and salbutamol on human bronchial smooth muscle cell proliferation. (18th December 2012) Authors: Fogli, S; Stefanelli, F; Picchianti, L; Del Re, M; Mey, V; Bardelli, C; Danesi, R; Breschi, MC Journal: British journal of pharmacology Issue: Volume 168:Number 1(2013:Jan.) Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗